We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+5.29%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$15.9B
AUM Growth
+$2.21B
(+16%)
Cap. Flow
+$1.83B
Cap. Flow
% of AUM
11.45%
Top 10 Holdings %
Top 10 Hldgs %
18.65%
Holding
1,314
New
180
Increased
461
Reduced
417
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$392M |
| 2 |
Alibaba
BABA
|
+$174M |
| 3 |
Broadcom
AVGO
|
+$165M |
| 4 |
Becton Dickinson
BDX
|
+$161M |
| 5 |
Aon
AON
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$161M |
| 2 |
General Motors
GM
|
+$107M |
| 3 |
Qualcomm
QCOM
|
+$105M |
| 4 |
Verizon
VZ
|
+$81.1M |
| 5 |
Citigroup
C
|
+$63.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.05% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Financials | 12.43% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STOR
401
DELISTED
STORE Capital Corporation
STOR
| $6.28M | 0.04% |
279,663
+239,133
| +590% | +$5.29M |
|
402
Encompass Health
EHC
$12.4B
| $6.19M | 0.04% |
160,758
-38,257
| -19% | -$1.4M |
|
403
Charter Communications
CHTR
$17.7B
| $6.11M | 0.04% |
18,143
+15,900
| +709% | +$5.3M |
|
404
W.R. Berkley
WRB
$26.1B
| $6.05M | 0.04% |
294,985
-40,736
| -12% | -$825K |
|
405
Crane NXT
CXT
$2.96B
| $6.01M | 0.04% |
217,868
+2,735
| +1% | +$73.9K |
|
|
MASI
406
DELISTED
Masimo
MASI
| $5.96M | 0.04% |
65,343
+7,190
| +12% | +$660K |
|
407
Essential Utilities
WTRG
$11.1B
| $5.86M | 0.04% |
176,077
-15,324
| -8% | -$502K |
|
408
Regions Financial
RF
$26.7B
| $5.83M | 0.04% |
397,961
-1,000
| -0.3% | -$14.1K |
|
|
ESRX
409
DELISTED
Express Scripts Holding Company
ESRX
| $5.82M | 0.04% |
91,217
-7,716
| -8% | -$485K |
|
410
First American
FAF
$7.38B
| $5.81M | 0.04% |
129,927
-35,720
| -22% | -$1.51M |
|
|
TARO
411
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $5.76M | 0.04% |
51,420
-4,379
| -8% | -$495K |
|
412
Curtiss-Wright
CW
$25.3B
| $5.76M | 0.04% |
62,745
+8,220
| +15% | +$741K |
|
413
Celanese
CE
$4.82B
| $5.75M | 0.04% |
60,620
-130
| -0.2% | -$11.6K |
|
|
LSI
414
DELISTED
Life Storage, Inc.
LSI
| $5.69M | 0.04% |
115,149
+20,179
| +21% | +$1.05M |
|
415
Bio-Techne
TECH
$11.3B
| $5.66M | 0.04% |
192,832
+68,632
| +55% | +$1.88M |
|
|
RTN
416
DELISTED
Raytheon Company
RTN
| $5.66M | 0.04% |
35,070
+7,357
| +27% | +$1.17M |
|
417
Weibo
WB
$1.94B
| $5.64M | 0.04% |
+84,791
| New | +$5.5M |
|
|
DRE
418
DELISTED
Duke Realty Corp.
DRE
| $5.63M | 0.04% |
201,345
-300
| -0.1% | -$8.43K |
|
419
Xcel Energy
XEL
$47.9B
| $5.62M | 0.04% |
122,502
+44,375
| +57% | +$2.04M |
|
420
Synchrony
SYF
$25.2B
| $5.62M | 0.04% |
188,355
-1,721,529
| -90% | -$51M |
|
421
Henry Schein
HSIC
$9.77B
| $5.53M | 0.03% |
76,985
-255
| -0.3% | -$17.8K |
|
422
International Flavors & Fragrances
IFF
$21.5B
| $5.52M | 0.03% |
40,904
| – | – |
|
423
Cinemark Holdings
CNK
$4.23B
| $5.38M | 0.03% |
138,540
+27,640
| +25% | +$1.15M |
|
424
Mondelez International
MDLZ
$78.6B
| $5.33M | 0.03% |
123,392
-1,050
| -0.8% | -$47.3K |
|
425
D.R. Horton
DHI
$40.7B
| $5.33M | 0.03% |
154,103
-759,753
| -83% | -$25.4M |
|
Similar funds
KK
VAI
UIM
Los Angeles Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Los Angeles Capital Management held 1,314 positions worth $15.9B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Los Angeles Capital Management deployed $1.83B of net new capital in Q2 2017, opening 180 new positions and adding to 461 existing holdings. Its largest new stake was Alibaba: 1,406,114 shares worth $198M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Gilead Sciences, an estimated $161M trimmed.
- Los Angeles Capital Management's largest Q2 2017 buy was Alibaba: 1,406,114 shares worth $198M.
- Los Angeles Capital Management added most to Amazon in Q2 2017, an estimated $392M increase.
- Los Angeles Capital Management's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $161M.
- Los Angeles Capital Management fully exited Harley-Davidson in Q2 2017, selling an estimated $56.4M.
- Los Angeles Capital Management's ten largest holdings make up 19% of its $15.9B portfolio in Q2 2017.
- Los Angeles Capital Management opened 180 new positions and closed 129 in Q2 2017.
- Los Angeles Capital Management's portfolio value rose 16% quarter-over-quarter to $15.9B.
Based on Los Angeles Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.